Spain – Vaccines – Acquisition of 20-valent pneumococcal conjugate vaccines
The purpose of the contract is the acquisition of 6,200 doses of 20-valent pneumococcal conjugate vaccines, including the following serotypes: 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F,
Opportunity description
The purpose of the contract is the acquisition of 6,200 doses of 20-valent pneumococcal conjugate vaccines, including the following serotypes: 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F, in order to meet the needs of vaccination centers so as to comply with the administration of vaccinations to adults turning 65, as well as to risk groups. Procedure: neg-wo-call. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.